Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa

NCT01670500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cisplatin
DRUG: Cyclophosphamide
DRUG: Doxorubicin

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]